Intranasal Drug Delivery: How, Why and What for?
Open accessThe DOI matches its Crossref record; 174 of the 175 references it cites were found in a registry or an index.
Abstract
Over the last decade the interest in intranasal delivery as a non-invasive route for drug administration has been exponentially increased. Since the nasal mucosa offers numerous benefits as a target issue for drug delivery, a wide variety of therapeutic compounds may be administered intranasally for topic, systemic and central nervous system action. The present paper reviews the relevant aspects of nasal anatomy, physiology and histology, and refers to the biological, physicochemical and pharmaceutical factors that must be considered during the process of discovery and development of nasal drugs as well as in their incorporation in appropriate nasal pharmaceutical formulations.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“It is non-invasive, painless, non-stressful, and relatively easy to perform without requiring a medical specialist [246,247,248].”
From Alzheimer's Disease: Treatment Strategies and Their Limitations. (2022) · cites this paper as [248]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Introduction and General Overview of Cyclodextrin Chemistry
Szejtli, J. (1998) · Chemical Reviews · doi:10.1021/cr970022c · Cited by 5,016
Chitosan Chemistry and Pharmaceutical Perspectives
Kumar, M. N. V. R., Muzzarelli, R. A. A., Muzzarelli, C., Sashiwa, H., & Domb, A. J. (2004) · Chemical Reviews · doi:10.1021/cr030441b · Cited by 2,938
Encyclopedia of Pharmaceutical Technology
Swarbrick, J. (2013) · CRC Press eBooks · doi:10.1201/b19309 · Cited by 1,794
Encyclopedia of pharmaceutical technology
(2003) · Choice Reviews Online · doi:10.5860/choice.40-6157 · Cited by 1,743
Abramson, M. H. (1996) · The Endocrinologist · doi:10.1097/00019616-199603000-00014 · Cited by 1,400
The Lung: Scientific Foundations
(1991) · Annals of Internal Medicine · doi:10.7326/0003-4819-115-6-503_2 · Cited by 1,190
Nasal drug delivery—possibilities, problems and solutions
Illum, L. (2003) · Journal of Controlled Release · doi:10.1016/s0168-3659(02)00363-2 · Cited by 1,102
Thorne, R. G., Pronk, G. J., Padmanabhan, V., & Frey, W. H. (2004) · Neuroscience · doi:10.1016/j.neuroscience.2004.05.029 · Cited by 958
Transport of drugs from the nasal cavity to the central nervous system
Illum, L. (2000) · European Journal of Pharmaceutical Sciences · doi:10.1016/s0928-0987(00)00087-7 · Cited by 907
Hanson, L. R., & Frey, W. H. (2008) · BMC Neuroscience · doi:10.1186/1471-2202-9-s3-s5 · Cited by 697
Research works printed but not linked: 5
- [27]27. Stevens A., Lowe J., Human histology, Mosby, Philadelphia, USA, 1997.
- [35]35. Dae-Duk Ki, Drug Absorption Studies: In situ, In vitro and In silico models, chapter 9, Springer, USA, 2007.
- [56]56. Varshosaz J, Sadrai H, Heidari A. Nasal delivery of insulin using bioadhesive chitosan gels. Drug Deliv, 2006; 13:31-38.
- [72]72. Belshe RB, Newman FK, Anderson EL, Wright PF, Karron RA, Tollefson S, Henderson FW, Meissner HC, Madhi S, Roberton D, Marshall H, Loh R, Sly P, Murphy B, Tatem JM, Randolph V, Hackell J, Gruber W, Tsai TF. Evaluation of combined live, attenuated respiratory syncytial virus and parainfluenza 3 virus in infants and young children. J Infect Dis, 2004; 190:2096-2103.
- [113]113. Hussain A.A., Bawarshi-Nassar R., Huang C.H., Transnasal Systemic Medications. Elsevier, Amsterdam, 1985. 123.
Cited by
Items 201–300 of 661
Development of adenoviral vector-based mucosal vaccine against influenza
Тутыхина, И. Л., Logunov, D. Y., Щербинин, Д. Н., Шмаров, М. М., Ильдарович, Т. А., Naroditsky, B. S., & Al, G. (2010) · Journal of Molecular Medicine · doi:10.1007/s00109-010-0696-0 · Cited by 43
Pharmacokinetics of a new, nasal formulation of naloxone
Tylleskär, I., Skulberg, A. K., Nilsen, T., Skarra, S., Jansook, P., & Dale, O. (2017) · European Journal of Clinical Pharmacology · doi:10.1007/s00228-016-2191-1 · Cited by 43
Esposito, E., Cortesi, R., Drechsler, M., Fan, J., Fu, B. M., Calderan, L., Mannucci, S., Boschi, F., & Nastruzzi, C. (2017) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2017.04.011 · Cited by 41
Drug delivery in overcoming the blood–brain barrier: role of nasal mucosal grafting
Marianecci, C., Rinaldi, F., Hanieh, P. N., Di Marzio, L., Paolino, D., & Carafa, M. (2017) · Drug Design, Development and Therapy · doi:10.2147/dddt.s100075 · Cited by 40
Khunt, D., Shrivas, M., Polaka, S., Gondaliya, P., & Misra, M. (2020) · AAPS PharmSciTech · doi:10.1208/s12249-019-1585-7 · Cited by 49
Topical Drug Delivery for Chronic Rhinosinusitis
Liang, J. Z., & Lane, A. P. (2012) · Current Otorhinolaryngology Reports · doi:10.1007/s40136-012-0003-4 · Cited by 44
Effect of three-drug delivery modalities on olfactory function in chronic sinusitis
Reychler, G., Colbrant, C., Huart, C., Guellec, S. L., Vecellio, L., Liistro, G., & Rombaux, P. (2014) · The Laryngoscope · doi:10.1002/lary.24937 · Cited by 41
Fine, J. M., Forsberg, A. C., Renner, D. B., Faltesek, K. A., Mohan, K., Wong, J. C., Arneson, L. C., Crow, J. M., Frey, W. H., & Hanson, L. R. (2014) · Brain Research · doi:10.1016/j.brainres.2014.05.048 · Cited by 45
Advances in nasal drug delivery systems
Hussein, N., Omer, H. K., Elhissi, A. M. A., & Ahmed, W. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-819712-7.00015-2 · Cited by 40
Diagnostic and Therapeutic Uses of Nanomaterials in the Brain
Garbayo, E., de Mendoza, A. E., & Blanco‐Prieto, M. J. (2014) · Current Medicinal Chemistry · doi:10.2174/0929867321666140815124246 · Cited by 40
Development of a nanogel-based nasal vaccine as a novel antigen delivery system
Nakahashi-Ouchida, R., Yuki, Y., & Kiyono, H. (2017) · Expert Review of Vaccines · doi:10.1080/14760584.2017.1395702 · Cited by 38
Intranasal insulin and orexins to treat age-related cognitive decline
Erichsen, J. M., Calva, C. B., Reagan, L. P., & Fadel, J. R. (2021) · Physiology & Behavior · doi:10.1016/j.physbeh.2021.113370 · Cited by 38
Bioengineered Biomimetic and Bioinspired Noninvasive Drug Delivery Systems
Rahamim, V., & Azagury, A. (2021) · Advanced Functional Materials · doi:10.1002/adfm.202102033 · Cited by 41
Strategies for the delivery of antidiabetic drugs via intranasal route
Dholakia, J., Prabhakar, B. R., & Shende, P. K. (2021) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2021.121068 · Cited by 38
Sharma, N., Zahoor, I., Sachdeva, M., Subramaniyan, V., Fuloria, S., Fuloria, N. K., Naved, T., Bhatia, S., Al‐Harrasi, A., Aleya, L., et al. (2021) · Environmental Science and Pollution Research · doi:10.1007/s11356-021-16570-y · Cited by 38
Santiago, J. C. P., & Hallschmid, M. (2019) · Experimental Neurology · doi:10.1016/j.expneurol.2019.03.007 · Cited by 39
Kumar, M., Dogra, R., & Mandal, U. K. (2022) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2022.103533 · Cited by 40
Is RPMI 2650 a Suitable In Vitro Nasal Model for Drug Transport Studies?
Mercier, C., Perek, N., & Delavenne, X. (2017) · European Journal of Drug Metabolism and Pharmacokinetics · doi:10.1007/s13318-017-0426-x · Cited by 37
Formulation strategies for nose-to-brain delivery of therapeutic molecules
Pandey, V., Gadeval, A., Asati, S., Jain, P., Jain, N., Roy, R. K., Tekade, M., Soni, V., & Tekade, R. K. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-814487-9.00007-7 · Cited by 45
Potential of phytochemicals as immune-regulatory compounds in atopic diseases: A review
Sharma, S. K., & Naura, A. S. (2020) · Biochemical Pharmacology · doi:10.1016/j.bcp.2019.113790 · Cited by 39
Charalambous, M., Volk, H. A., Ham, L. V., & Bhatti, S. F. M. (2021) · BMC Veterinary Research · doi:10.1186/s12917-021-02805-0 · Cited by 40
Recent advances in nanotechnology for Intra-nasal drug delivery and clinical applications
Rai, G., Gauba, P., & Dang, S. (2023) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2023.104726 · Cited by 44
Lee, D., Shen, A. M., Garbuzenko, O. B., & Minko, T. (2024) · The AAPS Journal · doi:10.1208/s12248-024-00967-x · Cited by 40
Di, A., Zhang, S., Liu, X., Tong, Z., Sun, S., Tang, Z., Chen, X. D., & Wu, W. D. (2020) · Powder Technology · doi:10.1016/j.powtec.2020.10.061 · Cited by 35
Alsaidan, O. A., Elkomy, M. H., Zaki, R. M., Tulbah, A. S., Yusif, R. M., & Eid, H. M. (2024) · Journal of Pharmaceutical Sciences · doi:10.1016/j.xphs.2024.08.026 · Cited by 34
Guennoun, R., Fréchou, M., Gaignard, P., Lière, P., Slama, A., Schumacher, M., Denier, C., & Mattern, C. (2018) · Neuropharmacology · doi:10.1016/j.neuropharm.2018.06.006 · Cited by 34
Recent advances on drug delivery applications of mucopenetrative/mucoadhesive particles: A review
Puri, V., Kaur, V. P., Singh, A., & Singh, C. (2022) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2022.103712 · Cited by 35
Pandya, J. D., Musyaju, S., Modi, H. R., Okada-Rising, S. L., Bailey, Z. S., Scultetus, A. H., & Shear, D. A. (2024) · Journal of Translational Medicine · doi:10.1186/s12967-024-04908-2 · Cited by 37
Tsze, D. S., Lubell, T. R., Carter, R., Chernick, L. S., DePeter, K. C., McLaren, S. H., Kwok, M. Y., Roskind, C. G., Gonzalez, A. E., Fan, W., et al. (2021) · Academic Emergency Medicine · doi:10.1111/acem.14422 · Cited by 34
D’Angelo, D., Kooij, S., Verhoeven, F. M., Sonvico, F., & van Rijn, C. J. M. (2022) · Journal of Advanced Research · doi:10.1016/j.jare.2022.04.011 · Cited by 33
Rigaut, C., Deruyver, L., Goole, J., Haut, B., & Lambert, P. (2022) · Frontiers in Medical Technology · doi:10.3389/fmedt.2022.924501 · Cited by 34
Application of ionic liquid to enhance the nose-to-brain delivery of etodolac
Tanigawa, H., Suzuki, N., & Suzuki, T. (2022) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2022.106290 · Cited by 35
Bancke, L. L., Dworak, H., Rodvold, K. A., Halvorsen, M. B., & Gidal, B. E. (2015) · Epilepsia · doi:10.1111/epi.13131 · Cited by 39
Electro-physiological changes in the brain induced by caffeine or glucose nasal spray
Pauw, K. D., Roelands, B., Cutsem, J. V., Marušič, U., Torbeyns, T., & MEEUSEN, R. R. (2016) · Psychopharmacology · doi:10.1007/s00213-016-4435-2 · Cited by 38
Khunt, D., Shah, B. M., & Misra, M. (2017) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2017.05.004 · Cited by 33
Charalambous, M., Volk, H. A., Tipold, A., Erath, J., Hünerfauth, E., Gallucci, A., Gandini, G., Hasegawa, D., Pancotto, T. E., Rossmeisl, J. H., et al. (2019) · Journal of Veterinary Internal Medicine · doi:10.1111/jvim.15627 · Cited by 35
Nazar, H., Caliceti, P., Carpenter, B. G., El‐Mallah, A., Fatouros, D. G., Roldo, M., van der Merwe, S. M., & Tsibouklis, J. (2012) · Biomaterials Science · doi:10.1039/c2bm00132b · Cited by 34
Bartos, C., Varga, P., Szabó‐Révész, P., & Ambrus, R. (2021) · Pharmaceutics · doi:10.3390/pharmaceutics13050608 · Cited by 32
Efficacy of intranasal administration of artesunate in experimental cerebral malaria
Marijon, A., Bonnot, G., Fourier, A., Bringer, C., Lavoignat, A., Gagnieu, M., Bienvenu, A., & Picot, S. (2014) · Malaria Journal · doi:10.1186/1475-2875-13-501 · Cited by 35
Upadhyay, R. K., Ghosh, P., & Desavathu, M. (2024) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2024.124866 · Cited by 32
Mercier, C., Hodin, S., Hé, Z., Perek, N., & Delavenne, X. (2018) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.8b00087 · Cited by 31
Neuropharmacology of attention
Burk, J. A., Blumenthal, S. A., & Maness, E. B. (2018) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2018.08.008 · Cited by 35
Recent Applications of Nanoemulsion Based Drug Delivery System: A Review
Eqbal, A., Ansari, V. A., Hafeez, A., Ahsan, F., Imran, M., & Tanweer, S. (2021) · Research Journal of Pharmacy and Technology · doi:10.52711/0974-360x.2021.00502 · Cited by 31
Merelli, A., Caltana, L. R., Girimonti, P., Ramos, A. J., Lazarowski, A., & Brusco, A. (2010) · Neurotoxicity Research · doi:10.1007/s12640-010-9233-8 · Cited by 31
Peptide Therapeutics: it‘s All in the Delivery
GRANT, M. L., & Leone‐Bay, A. (2012) · Therapeutic Delivery · doi:10.4155/tde.12.79 · Cited by 30
Hernández‐Parra, H., Cortés, H., Ávalos‐Fuentes, J. A., Prado-Audelo, M. L. D., Florán, B., Leyva‐Gómez, G., Sharifi‐Rad, J., & Cho, W. C. S. (2022) · Journal of Nanobiotechnology · doi:10.1186/s12951-022-01612-5 · Cited by 33
The prescription design and key properties of nasal gel for CNS drug delivery: A review
Wang, M., Ma, X., Zong, S., Su, Y., Su, R., Zhang, H., Liu, Y., Wang, C., & Li, Y. (2023) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2023.106623 · Cited by 36
Positron Emission Tomography Assessment of the Intranasal Delivery Route for Orexin A
de Bittner, G. C. V., de Bittner, K. C. V., Wey, H., Rowe, W. B., Dharanipragada, R., Ying, X., Hurst, W., Giovanni, A., Alving, K., Gupta, A., et al. (2017) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.7b00357 · Cited by 31
A REVIEW ON NASAL DRUG DELIVERY SYSTEM AND ITS CONTRIBUTION IN THERAPEUTIC MANAGEMENT
Alnasser, S. M. (2019) · Asian Journal of Pharmaceutical and Clinical Research · doi:10.22159/ajpcr.2018.v12i1.29443 · Cited by 30
The Development of an In Vitro Horizontal Diffusion Cell to Monitor Nasal Powder Penetration Inline
Gieszinger, P., Kiss, T., Szabó‐Révész, P., & Ambrus, R. (2021) · Pharmaceutics · doi:10.3390/pharmaceutics13060809 · Cited by 29
Shan, X., Aspinall, S. R., Kaldybekov, D. B., Buang, F., Williams, A. C., & Khutoryanskiy, V. V. (2021) · ACS Applied Polymer Materials · doi:10.1021/acsapm.1c01097 · Cited by 30
Mesenchymal Stem Cell-Derived Exosome Therapy of Microbial Diseases: From Bench to Bed
Wu, X., Jin, S., Ding, C., Wang, Y., He, D., & Liu, Y. (2022) · Frontiers in Microbiology · doi:10.3389/fmicb.2021.804813 · Cited by 30
Intranasal Opioid Administration in Rhesus Monkeys: PET Imaging and Antinociception
Saccone, P. A., Lindsey, A. M., Koeppe, R. A., Zelenock, K. A., Shao, X., Sherman, P. S., Quesada, C., Woods, J. H., & Scott, P. J. H. (2016) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.116.235192 · Cited by 31
Withania somnifera as a potential future drug molecule for COVID-19
Kashyap, V. K., Dhasmana, A., Yallapu, M. M., Chauhan, S. C., & Jaggi, M. (2020) · Future Drug Discovery · doi:10.4155/fdd-2020-0024 · Cited by 29
Guzman, C. B., Dulude, H., Piché, C., Rufiange, M., Sadoune, A. A., Rampakakis, E., Carballo, D., Triest, M., Zhang, M. X., Zhang, S., et al. (2018) · Diabetes, Obesity and Metabolism · doi:10.1111/dom.13134 · Cited by 28
“Nasal administration is effective for delivery of medications and vaccines.(10) The human nasal cavity has a volume of 15 to 20 mL and a surface area of approximately 150 cm(2).”
BackgroundThe nasal route for nose-to-brain drug delivery: advanced nasal formulations for CNS disorders
Papakyriakopoulou, P., & Valsami, G. N. (2025) · Expert Opinion on Drug Delivery · doi:10.1080/17425247.2025.2489553 · Cited by 35
Drug Transporters in the Nasal Epithelium: An Overview of Strategies in Targeted Drug Delivery
Anand, U., Parikh, A. R., Ugwu, M. C., & Agu, R. U. (2014) · Future Medicinal Chemistry · doi:10.4155/fmc.14.77 · Cited by 30
In Vitro Assessment of Spray Deposition Patterns in a Pediatric (12 Year-Old) Nasal Cavity Model
Sawant, N., & Donovan, M. D. (2018) · Pharmaceutical Research · doi:10.1007/s11095-018-2385-6 · Cited by 28
Shah, P., Sarolia, J., Vyas, B., Wagh, P., Ankur, K., & Mishra, A. K. (2020) · Current Drug Delivery · doi:10.2174/1567201817666200708115627 · Cited by 30
Hou, H., Li, Y., Xu, Z., Yu, Z., Peng, B., Wang, C., Liu, W., Li, W., Ye, Z., & Zhang, G. (2022) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2022.113933 · Cited by 28
Józsa, G., Oo, T. Z., Amukune, S., & Józsa, K. (2022) · Education Sciences · doi:10.3390/educsci12120906 · Cited by 32
Weiland, L., Kluge, K., Kutter, A. P. N., & Kronen, P. (2016) · Veterinary Anaesthesia and Analgesia · doi:10.1111/vaa.12408 · Cited by 27
Polymeric nanoparticles for efficient nose-to-brain delivery
Bolon, M., Fieux, M., Monge, C., & Richard, S. (2025) · Nanoscale · doi:10.1039/d5nr00870k · Cited by 29
Potential Role of Xylitol Plus Grapefruit Seed Extract Nasal Spray Solution in COVID-19: Case Series
Go, C. C., Pandav, K. B., Sanchez‐Gonzalez, M. A., & Ferrer, G. (2020) · Cureus · doi:10.7759/cureus.11315 · Cited by 31
Dhuyvetter, D., Tekle, F. B., Nazarov, M., Vreeken, R. J., Borghys, H., Rombouts, F. J. R., Lenaerts, I., & Bottelbergs, A. (2020) · Drug Delivery · doi:10.1080/10717544.2020.1837291 · Cited by 26
Kiran, P., Debnath, S. K., Neekhra, S., Pawar, V. S., Khan, A., Dias, F., Pallod, S., & Srivastava, R. (2021) · Wiley Interdisciplinary Reviews Nanomedicine and Nanobiotechnology · doi:10.1002/wnan.1768 · Cited by 26
Excipients Used for Modified Nasal Drug Delivery: A Mini-Review of the Recent Advances
Protopapa, C., Siamidi, A., Pavlou, P., & Vlachou, M. (2022) · Materials · doi:10.3390/ma15196547 · Cited by 26
Fuchigami, T., Itokazu, Y., Morgan, J. C., & Yu, R. K. (2023) · Molecular Neurobiology · doi:10.1007/s12035-023-03282-2 · Cited by 27
Zhang, G., Shi, G., Tan, H., Kang, Y., & Cui, H. (2011) · Hormones and Behavior · doi:10.1016/j.yhbeh.2011.01.007 · Cited by 27
Use of Intranasal Ketamine in Pediatric Patients in the Emergency Department
Guthrie, A. M., Baum, R. A., Carter, C., Dugan, A. J., Jones, L. A., Tackett, T., & Bailey, A. M. (2019) · Pediatric Emergency Care · doi:10.1097/pec.0000000000001863 · Cited by 26
Main plant extracts’active properties effective on scopolamine-induced memory loss
Balmus, I.-M., & Ciobica, A. (2017) · American Journal of Alzheimer's Disease & Other Dementiasr · doi:10.1177/1533317517715906 · Cited by 25
Microemulsion as a promising carrier for nose to brain delivery: journey since last decade
Shah, B. M. (2021) · Journal of Pharmaceutical Investigation · doi:10.1007/s40005-021-00528-w · Cited by 29
Hassan, R. H., Gad, H. A., El-Din, S. B., Shaker, D. S., & Ishak, R. A. H. (2022) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2022.122278 · Cited by 25
Namazi, H., & Jafarirad, S. (2011) · Journal of Pharmacy & Pharmaceutical Sciences · doi:10.18433/j3zc73 · Cited by 27
Sánchez-López, J. A., Ziere, A., Martins, S. I. F. S., Zimmermann, R., & Yeretzian, C. (2016) · Journal of Breath Research · doi:10.1088/1752-7155/10/3/036005 · Cited by 25
Berg, A. K., Myrvik, M. J., & Ess, P. J. V. (2017) · Epilepsy & Behavior · doi:10.1016/j.yebeh.2017.02.023 · Cited by 25
Gangurde, P. K., Bhaskaran, N. A., & Kumar, L. (2018) · Journal of Pharmaceutical Innovation · doi:10.1007/s12247-018-9343-z · Cited by 27
Elkarray, S. M., Farid, R. M., Abd-Alhaseeb, M. M., Omran, G. A., & Habib, D. A. (2022) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2021.103086 · Cited by 28
Sayyed, M. E., Motaleb, M. A., Ibrahim, I. T., Rashed, H. M., El-Nabarawi, M. A., & Ahmed, M. A. (2021) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2021.106089 · Cited by 24
Clinical trials of intranasal delivery for treating neurological disorders – a critical review
Liu, X. (2011) · Expert Opinion on Drug Delivery · doi:10.1517/17425247.2011.633508 · Cited by 25
Al-Ghabeish, M., Scheetz, T. E., Assem, M., & Donovan, M. D. (2015) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.5b00103 · Cited by 24
Williams, A. J., Jordan, F., King, G., Lewis, A. L., Illum, L., Masud, T., Perkins, A. C., & Pearson, R. G. (2017) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2017.10.029 · Cited by 25
Shibuya, K., Morikawa, S., Miyamoto, M., Ogawa, S.-I., Tsunenari, Y., Urano, Y., & Noguchi, N. (2019) · ACS Omega · doi:10.1021/acsomega.9b02307 · Cited by 23
Intranasal Administration as a Route to Deliver Drugs to the Brain (Review)
Porfiryeva, N. N., Семина, И. И., Moustafine, R. I., & Khutoryanskiy, V. V. (2021) · Drug development & registration · doi:10.33380/2305-2066-2021-10-4-117-127 · Cited by 25
Fouad, G. I., El‐Sayed, S. A. M., Mabrouk, M., Ahmed, K. A., & Beherei, H. H. (2022) · Neurotoxicity Research · doi:10.1007/s12640-022-00555-x · Cited by 24
Ghazwani, M., Vasudevan, R., Kandasamy, G., Naredla, M., Devanandan, P., Puvvada, R. C., Veeramani, V. P., Paulsamy, P., Venkatesan, K., Chidmabaram, K., et al. (2023) · Gels · doi:10.3390/gels9060457 · Cited by 23
Pisal, P. B., Patil, S. S., & Pokharkar, V. (2012) · Drug Development and Industrial Pharmacy · doi:10.3109/03639045.2012.692377 · Cited by 23
Yousfan, A., Rubio, N., Al‐Ali, M., Nattouf, A. H., & Kafa, H. (2021) · Biomaterials Science · doi:10.1039/d1bm01251g · Cited by 24
Farzampour, S., Majdi, A., & Sadigh‐Eteghad, S. (2016) · Physiology International · doi:10.1556/2060.103.2016.3.7 · Cited by 22
Feyzabadi, Z., Rezaeitalab, F., Aval, S. B., Taghipour, A., Moharari, F., Soltanifar, A., & Ahmadpour, M. R. (2017) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2017.11.036 · Cited by 23
Sivadasu, P., Gowda, D. V., Subramani, N. K., Vishweshwaraiah, B. M., Shivanna, S., & Siddaramaiah, H. (2019) · Indian Journal of Pharmaceutical Education and Research · doi:10.5530/ijper.54.1.9 · Cited by 24
A cohort study of intranasal fentanyl for procedural pain management in neonates
McNair, C., Graydon, B., & Taddio, A. (2018) · Paediatrics & Child Health · doi:10.1093/pch/pxy060 · Cited by 21
Polymers in Nasal Drug Delivery: An Overview
Javia, A., Kore, G. G., & Misra, A. R. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-819659-5.00011-2 · Cited by 22
An overview of anatomical and physiological aspects of the nose and the brain
Khunt, D., & Misra, M. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-822522-6.00029-1 · Cited by 28
Tekade, A. R., Suryavanshi, M. R., Shewale, A. B., & Patil, V. (2023) · Drug Development and Industrial Pharmacy · doi:10.1080/03639045.2023.2262035 · Cited by 26
Lao, C. L., Kuo, Y.-H., Hsieh, Y.-T., & Chen, J. (2013) · Neurotoxicity Research · doi:10.1007/s12640-013-9408-1 · Cited by 21
Sinha, S., Garg, V., Sonali, Singh, R. P., & Dutt, R. (2021) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2021.102645 · Cited by 21
Pires, P. C., Fazendeiro, A. C., Rodrigues, M., Alves, G., & Santos, A. O. (2021) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2021.105918 · Cited by 21
Self-citationModaresi, M. A. (2022) · Biomechanics and Modeling in Mechanobiology · doi:10.1007/s10237-022-01645-7 · Cited by 21
From naturally-occurring neurotoxic agents to CNS shuttles for drug delivery
Soddu, E., Rassu, G., Giunchedi, P., Sarmento, B. F. C. C., & Gavini, E. (2015) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2015.04.005 · Cited by 23
Metadata
- Authors
- Pires, A., Fortuna, A., Alves, G., & Falcão, A.
- Affiliations
- University of Coimbra (PT)
- University of Beira Interior (PT)
- Venue
- Journal of Pharmacy & Pharmaceutical Sciences
- Publisher
- Frontiers Media SA
- Published
- 2009-10-12
- Volume
- 12
- Issue
- 3
- Pages
- 288
- ISSN
- 1482-1826 (ISSN-L)
- OpenAlex
- W2106536537
- Cited by
- 641
- References
- 175
- Citations by year
- 2026: 31 · 2025: 49 · 2024: 44 · 2023: 45 · 2022: 67 · 2021: 65 · 2020: 48 · 2019: 41 · 2018: 35 · 2017: 42 · 2016: 35 · 2015: 29 · 2014: 32 · 2013: 25 · 2012: 23
- FWCI
- 1.76
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by
- Locations
- Journal of Pharmacy & Pharmaceutical Sciences (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Portuguese National Funding Agency for Science, Research and Technology (RCAAP Project by FCT) (submittedVersion, other-oa)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Portuguese National Funding Agency for Science, Research and Technology (RCAAP Project by FCT) (submittedVersion)
- Portuguese National Funding Agency for Science, Research and Technology (RCAAP Project by FCT) (submittedVersion, cc-by-sa)
- Funders
- Fundação para a Ciência e a Tecnologia (SFRH/BD/45145/2008)
- Topics
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmaceutical Science › Advanced Drug Delivery Systems
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Inhalation and Respiratory Drug Delivery
- Health Sciences › Medicine › Otorhinolaryngology › Sinusitis and nasal conditions
- Keywords
- intranasal drug delivery, nasal mucosa, transmucosal drug absorption, brain drug delivery, topical drug delivery, systemic drug delivery
- MeSH terms
- Absorption, Administration, Intranasal, Animals, Biological Availability, Humans, Nasal Cavity, Nasal Mucosa, Drug Discovery
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.